Your browser doesn't support javascript.
loading
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability.
Huttner, Angela; Agnandji, Selidji Todagbe; Engler, Olivier; Hooper, Jay W; Kwilas, Steve; Ricks, Keersten; Clements, Tamara L; Jonsdottir, Hulda R; Nakka, Sravya Sowdamini; Rothenberger, Sylvia; Kremsner, Peter; Züst, Roland; Medaglini, Donata; Ottenhoff, Tom; Harandi, Ali M; Siegrist, Claire-Anne.
Affiliation
  • Huttner A; Division of Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland; Clinical Trials Unit, Centre for Clinical Research, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland; Centre for Vaccinology, University Hospitals of Geneva and Faculty of Medicine, Genev
  • Agnandji ST; Centre de Recherches Médicales de Lambaréné, Campus CERMEL, Lambaréné, Gabon; Institut für Tropenmedizin, Reisemedizin und Humanparasitologie Universitätsklinikum Tübingen, Tübingen, Germany; GermanCenter for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
  • Engler O; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
  • Hooper JW; Foundational Science Directorate, US Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
  • Kwilas S; Foundational Science Directorate, US Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
  • Ricks K; Foundational Science Directorate, US Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
  • Clements TL; Foundational Science Directorate, US Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
  • Jonsdottir HR; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
  • Nakka SS; Department of Microbiology and Immunology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Rothenberger S; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland; Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland.
  • Kremsner P; Centre de Recherches Médicales de Lambaréné, Campus CERMEL, Lambaréné, Gabon; Institut für Tropenmedizin, Reisemedizin und Humanparasitologie Universitätsklinikum Tübingen, Tübingen, Germany; GermanCenter for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
  • Züst R; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
  • Medaglini D; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Ottenhoff T; Department of Infectious Diseases, Leiden Hospital Centre and University Hospital, Leiden, The Netherlands.
  • Harandi AM; Department of Microbiology and Immunology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Vaccine Evaluation Centre, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.
  • Siegrist CA; Centre for Vaccinology, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland.
Clin Microbiol Infect ; 29(12): 1587-1594, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37661067
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Hemorrhagic Fever, Ebola / Ebola Vaccines / Ebolavirus / Vesicular Stomatitis Limits: Adult / Animals / Humans Country/Region as subject: Africa Language: En Journal: Clin Microbiol Infect Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Hemorrhagic Fever, Ebola / Ebola Vaccines / Ebolavirus / Vesicular Stomatitis Limits: Adult / Animals / Humans Country/Region as subject: Africa Language: En Journal: Clin Microbiol Infect Year: 2023 Document type: Article